A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)
Clinical trial NCT06943833 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06943833
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2028-03-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.